The trading price of Impact BioMedical Inc (AMEX:IBO) closed higher on Tuesday, May 06, and closing at $0.61, 1.63% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $6.17 and a 52-week low of $0.37. Over the past month, the stock has lost -36.66% in value.
Impact BioMedical Inc, whose market valuation is $7.01 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
A quick review shows that IBO’s price is currently 24.89% off the SMA20 and -42.12% off the SMA50. The RSI metric on the 14-day chart is currently showing 47.15, and weekly volatility stands at 31.99%. When measured over the past 30 days, the indicator reaches 19.91%. Impact BioMedical Inc (AMEX:IBO)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 0.24.
To see how Impact BioMedical Inc stock has been performing in comparison to its peers in the industry, here are the numbers: IBO stock’s performance was 1.63% in the latest trading.
An evaluation of the daily trading volume of Impact BioMedical Inc (AMEX:IBO) indicates that the 3-month average is 9.50 million.
Currently, records show that 11.50 million of the company’s shares remain outstanding. The insiders hold 12.50% of outstanding shares, whereasinstitutions hold 0.93%. However, since the stock’s price has seen -57.94% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
